நோயெதிர்ப்பு ஆராய்ச்சி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோயெதிர்ப்பு ஆராய்ச்சி குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோயெதிர்ப்பு ஆராய்ச்சி குழு Today - Breaking & Trending Today

A just vaccine roll-out, SA's school dropout rate and...

The sixth World NGO Day will be commemorated on Saturday, 27 February in more than 89 countries. An NGO is non-profit and is run by citizens outside of any government structure. There are an estimated 10 million NGOs in the world, employing about 50 million people. The number of NGOs is expected to double in the next decade.
The rest of the week…
On
Wednesday, 24 February, the digitalisation of South Africa’s social grant payments system will come under the spotlight. The Digital Welfare State and Human Rights Project will interview Lynette Maart, the director of Black Sash, on how it came to be that the country became dependent on just one company for the payment of grants. Listen in at 10am here. ....

South Africa , Western Cape , University Of The Western Cape , South African , Lydia Cairncross , Wolfgang Preiser , Dale Mckinley , Jantjie Taljaard , Fatima Hassan , Greg Hussey , Hassan Mahomed , Gerhard Walzl , Asanda Fotyi , Helmuth Reuter , Lynette Maart , Africa Shiferaw Teklemariam , Bernice Hlagala , Adrian Peters , Welile Nhlapo , Wits School Of Law , International Labour Research , Human Sciences Research Council , People Health Movement Of South Africa , Public Health , Information Group , Clinical Services ,

Dr. Richard Woodman Appointed Chief Clinical Officer of the Oncology Business Group at Eisai Inc.

Share this article
WOODCLIFF LAKE, N.J., Jan. 20, 2021 /PRNewswire/
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Dr. Richard Woodman as Chief Clinical Officer (CCLO) of its Oncology Business Group. In this role, Dr. Woodman will have full oversight and responsibility for the strategic and operational leadership of the company s global oncology clinical development functions, including clinical research, clinical operations, imaging, medical writing, data services, biostatistics and regulatory strategy. He will also serve as a member of the Oncology Executive Leadership team.
Dr. Richard Woodman
Dr. Woodman, who has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations, will lead the clinical team s development of Eisai s next generation oncology products by managing the design protocols and implementation of all oncology clinic ....

United States , New Jersey , North Carolina , Patricia Councill , Global Medical Affairs , Head Of Research , Division Of Hematology Hematological Malignancies , Eisai Inc , Eisai Co Ltd , Us Oncology Clinical Development , Research Institute , Department Of Experimental Medicine , University Of Calgary , Oncology Business Group At Eisai Inc , Immunology Research Group , Takashi Owa , Chief Medicine Creation Officer , Chief Discovery Officer , Oncology Business Group , Chief Medical Officer , Onconova Therapeutics , Clinical Development , Medical Affairs , Franchise Head , Global Medical , Senior Medical Director ,